Main Article Content
Gold-based metallodrugs have been used for a wide variety of medical–related applications. Although none of them have reached clinical trials, many compounds show potential for a plethora of possible applications. Platinum compounds, on the other hand, are the leading class of metallodrugs used for the treatment of cancer, with successful representatives worldwide, such as cisplatin, carboplatin and oxaliplatin. In this minireview, we will briefly present the development of metallodrugs based on such metals throughout the year of 2017.
Papers may not be offered for publication elsewhere whilst under consideration by the International Journal of Advances in Medical Biotechnology - IJAMB. The corresponding author must obtain the consent of all co-authors to the submission of the paper. Papers accepted by the Journal for publication may not be published elsewhere without the permission of the JOURNAL and acknowledgement of the original source of the publication.